Does the culture of science publishing need to change from the status quo principle of “trust me”?

Two recent editorials by Komorowski [1] and Oegalska-Trybalska This is because science publishing, including cancer research, is in a highly transformative -if not revolutionary -period. For authors and journals whose papers have been retracted, it is a painful period that may ultimately destroy their careers, reputations, and legends Some of that change is fueled by a desire from a segment of academia to replace the current publishing status quo, or the publishing oligopoly These are journals that have come to dominate fields of research, bolstered by indexing on powerful, prestigious and highly visible platforms (such as PubMed, Scopus, or Web of Science), and which have been assigned pseudo-quality metrics (the Clarivate impact factor or the Scopus CiteScore).